Lupin Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ABACAVIR SULFATE USP, with a corresponding US DMF Number 23618.
Remarkably, this DMF maintains an Active status since its submission on April 08, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 27, 2012, and payment made on November 20, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II